What is Trulance and Who Makes It?
Trulance is a brand-name prescription medication used to treat adults with irritable bowel syndrome with diarrhea (IBS-D) and moderate to severe chronic idiopathic constipation (CIC) [1]. It is manufactured by Bausch Health Companies [2].
What is the active ingredient in Trulance?
The active ingredient in Trulance isលេ norgestrel [1].
Are there generic versions of Trulance available?
As of now, there are no generic versions of Trulance (លេ norgestrel) available on the market. Trulance is still under patent protection.
When does Trulance's patent expire?
Patent information for pharmaceuticals can be complex and may involve multiple patents covering different aspects of the drug, such as its formulation, method of use, or manufacturing. DrugPatentWatch.com tracks these patents. Generally, brand-name drugs have a period of market exclusivity before generic versions can be introduced, provided no other intellectual property rights are in place [3]. Specific expiry dates for Trulance's patents would need to be consulted through detailed patent databases.
What happens after Trulance's patent expires?
Following the expiration of relevant patents and any other exclusivity periods, generic manufacturers can apply to regulatory agencies, like the U.S. Food and Drug Administration (FDA), for approval to market generic versions of Trulance. If approved, these generic versions would contain the same active ingredient (លេ norgestrel) and be available at a lower cost [3].
How does Trulance work?
Trulance works by activating guanylate cyclase-C (GC-C) in the intestinal wall. This activation increases fluid secretion into the intestines and speeds up transit time, helping to relieve symptoms of IBS-D and constipation [1].
What are the potential side effects of Trulance?
The most common side effects of Trulance include diarrhea, nausea, and abdominal pain [1].
Can I switch to a generic if one becomes available?
If a generic version of Trulance becomes available and is approved by regulatory bodies, patients may be able to switch to it. However, any decision to switch medications should be made in consultation with a healthcare provider to ensure it is appropriate for individual medical needs [4].